4DMedical Receives EU Approval for New Lung Imaging Technology

In March 2026, the Australian company 4DMedical reached a significant milestone by securing CE Mark certification for its innovative lung imaging technology, CT:VQ™.

org4DMedical

otherCE Mark

techCT:VQ™

This regulatory approval is a major step forward, enabling the company to introduce its product across the European Union.

locationEuropean Union

Unlike traditional nuclear medicine, CT:VQ™ is a non-invasive solution that creates detailed functional lung insights using standard, non-contrast CT scans.

conceptnuclear medicine

techCT:VQ™

techCT scan

This entry into the EU market—a region with over 450 million people—is a key part of 4DMedical's global expansion strategy.

org4DMedical

Following successful adoption in prestigious U.S. institutions like the Mayo Clinic and Stanford, the company is well-positioned for international growth.

orgMayo Clinic

orgStanford

To support this rollout, 4DMedical successfully raised AU$83 million from institutional investors.

org4DMedical

Founded in 2013 by Dr.

Andreas Fouras, 4DMedical continues to lead the way in integrating artificial intelligence into cardiothoracic imaging to improve the diagnosis and management of respiratory conditions worldwide.

org4DMedical

techartificial intelligence

🎉

End of article

You read 8 focus sentences.

Challenge Mode

Comprehension Questions

What primary advantage does the CT:VQ™ technology offer compared to traditional nuclear VQ scans?

It provides functional lung insights without needing radioactive tracers.

It relies on advanced nuclear medicine infrastructure.

It requires more contrast agents for higher image resolution.

Reveal Answer

✓

Correct Choice

It provides functional lung insights without needing radioactive tracers.

What does the CE Mark certification allow 4DMedical to do?

It allows the company to establish new nuclear medicine facilities.

It enables the commercial deployment of their technology across the European Union.

It grants permission to exclusively sell products in Australia.

Reveal Answer

✓

Correct Choice

It enables the commercial deployment of their technology across the European Union.

Why is the European market strategically important for 4DMedical?

It offers access to a large market of over 450 million people with existing CT infrastructure.

The EU has banned all other forms of traditional lung imaging.

The EU market lacks any existing CT scanner infrastructure.

Reveal Answer

✓

Correct Choice

It offers access to a large market of over 450 million people with existing CT infrastructure.

How did 4DMedical intend to fund its European expansion?

By closing its existing operations in the Cleveland Clinic.

By reducing its research and development budget in the U.S.

Through raising AU$83 million in a private placement to institutional investors.

Reveal Answer

✓

Correct Choice

Through raising AU$83 million in a private placement to institutional investors.

Who founded 4DMedical in 2013?

A group of investors from the Mayo Clinic.

A team of researchers from the European Union.

Dr. Andreas Fouras.

Reveal Answer

✓

Correct Choice

Dr. Andreas Fouras.

Learn faster with Ringoo apps

Trace your learning progress and get real-time feedback with interactive exercises.

App Store Google Play